Looking at the trades through the day it seems like it’s being pushed not sold down, often a normal sized trade pushing price up then a very small trade pushes back down. Much of the initial U.S generic pricing fears have eased, there’s tax cuts, probable higher U.S.D, apparently positive announcements & they sell needed products to a growing market! It would be nice to see a squeeze.
Ann: Mayne Pharma opens new US manufacturing facility, page-27
Add to My Watchlist
What is My Watchlist?
